(MIR) Mirion Technologies - Ratings and Ratios

Mirion Technologies, Inc. (NYSE:MIR) is a global leader in radiation detection, measurement, and monitoring solutions, operating across North America, Europe, and the Asia Pacific. The company is organized into two primary segments: Medical and Nuclear & Safety. The Medical segment specializes in radiation oncology quality assurance, patient safety solutions for diagnostic imaging and radiation therapy, and radionuclide therapy products for nuclear medicine. It provides dosimetry systems, radiation therapy calibration tools, and medical imaging furniture, enhancing the precision and safety of cancer treatment and diagnostics. The Nuclear & Safety segment addresses radiation safety, measurement, and analysis needs, offering personal radiation detection devices, identification equipment, and analysis tools. Its product portfolio also includes reactor instrumentation, waste management systems, laboratory analysis systems, and contamination monitors.

Mirion serves a diverse range of industries, including healthcare facilities, military organizations, government agencies, industrial companies, and nuclear power plants. The companys solutions are critical for ensuring safety and compliance in environments where radiation exposure is a concern. Mirion Technologies, Inc. was established in 2005 and is headquartered in Atlanta, Georgia. Formerly known as Global Monitoring Systems, Inc., it rebranded to Mirion Technologies in 2006. The company is listed on the NYSE under the ticker symbol MIR and falls under the Industrial Machinery & Supplies & Components sector.

Ticker Symbol: MIR Exchange: NYSE Type: common stock Country Origin: United States GICS Sub Industry: Industrial Machinery & Supplies & Components

Average Volume 20d: 1,414,064 Last Price: 15.32 SMA 20: 13.99 SMA 50: 14.68 SMA 200: 13.98 ATR: 0.73

Market Cap: 3,195.74M USD P/E: None P/E Forward: None P/B: 2.12 P/S: 3.71 RoE: -2.32

3-month forecast: Based on the technical and fundamental data, MIR is expected to remain in a consolidative range with potential volatility. The stock is currently trading above its 20-day and 50-day SMAs but below its 200-day SMA, indicating mixed momentum. The ATR of 0.73 suggests moderate price movement. Given the negative RoE and high P/S ratio, the stock may face headwinds. However, its strong market position and revenue streams could provide support. Expect MIR to trade between $14.00 and $16.00 over the next three months, with potential for a breakout if fundamentals improve.